Cargando…

Cost-effectiveness of physical activity in the management of COPD patients in the UK

BACKGROUND: While the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines advise exercise to reduce disease progression, little investment in promoting physical activity (PA) is made by health care authorities. The purpose of this study was to estimate the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramos, Mafalda, Lamotte, Mark, Gerlier, Laetitia, Svangren, Per, Miquel-Cases, Anna, Haughney, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339649/ https://www.ncbi.nlm.nih.gov/pubmed/30697043 http://dx.doi.org/10.2147/COPD.S181194

Ejemplares similares

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
por: Ramos, Mafalda, et al.
Publicado: (2016)

Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
por: Salem, Ahmed, et al.
Publicado: (2021)

Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
por: Ramos, Mafalda, et al.
Publicado: (2020)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China
por: Ramos, Mafalda, et al.
Publicado: (2021)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
por: Price, David, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
por: Ramos, Mafalda, et al.
Publicado: (2019)

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
por: Biskupiak, Joseph E, et al.
Publicado: (2023)

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
por: Ehlers, Lars H., et al.
Publicado: (2022)

Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy
por: McCrimmon, Rory J., et al.
Publicado: (2021)

Translation of the UK Pediatric Influenza Vaccination Programme in Primary Schools to 13 European Countries Using a Dynamic Transmission Model
por: Gerlier, Laetitia, et al.
Publicado: (2017)

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
por: Gerlier, Laetitia, et al.
Publicado: (2010)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
por: Fenwick, Elisabeth, et al.
Publicado: (2021)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
por: Martin, Alan, et al.
Publicado: (2022)

Physicians’ attitudes towards combination therapy with inhaled corticosteroids and long-acting β(2)-agonists: an observational study in UK specialist care
por: Thomas, Mike, et al.
Publicado: (2011)

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
por: Lopes, Sandra, et al.
Publicado: (2020)

Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
por: Yakutcan, Usame, et al.
Publicado: (2022)

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)
por: Haughney, John, et al.
Publicado: (2022)

Is iron deficiency modulating physical activity in COPD?
por: Martín-Ontiyuelo, Clara, et al.
Publicado: (2019)

Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions”
por: Lopes, Sandra, et al.
Publicado: (2020)

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden
por: Bilir, S Pinar, et al.
Publicado: (2018)

An economic evaluation of the healthcare cost of tinnitus management in the UK
por: Stockdale, David, et al.
Publicado: (2017)

Impact of the UK lockdown on people at risk of COPD
por: Donaldson, Gavin C., et al.
Publicado: (2021)

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
por: Wright, Antony, et al.
Publicado: (2022)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
por: Halpin, David M G, et al.
Publicado: (2022)

Cost-effectiveness of home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD in the UK
por: Murphy, Patrick Brian, et al.
Publicado: (2023)

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
por: Price, David, et al.
Publicado: (2014)

Direct and indirect effects of influenza vaccination
por: Eichner, Martin, et al.
Publicado: (2017)

An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders
por: Vandenplas, Yvan, et al.
Publicado: (2021)

Epidemiology and costs of hospital care for COPD in Puglia
por: Moretti, Anna Maria, et al.
Publicado: (2011)

Daily physical activity and related risk factors in COPD
por: Albarrati, Ali M., et al.
Publicado: (2020)

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
por: Buchanan, Vanessa, et al.
Publicado: (2018)

Pulmonary rehabilitation, physical activity and aortic stiffness in COPD
por: Aldabayan, Yousef S., et al.
Publicado: (2019)

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis
por: Hertel, Nadine, et al.
Publicado: (2012)

The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada
por: Lenoir-Wijnkoop, Irene, et al.
Publicado: (2016)

Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study
por: Pascual, Sergi, et al.
Publicado: (2015)

Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
por: Emery, Paul, et al.
Publicado: (2018)

Meeting the GOLD Standard: COPD Treatment in the UK Today
por: Calverley, P.M.A.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b8cuir80si19btrq9geh5uvss1